Poland· PL-100100490
Integrilin
A eptifibatide product containing eptifibatidum, registered in Poland by GlaxoSmithKline (Ireland) Limited. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Eptifibatide is registered in 15 of 19 countries.
Countries holding a registration under ATC B01AC16 (eptifibatide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Eptifibatide · ATC B01AC16
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Eptifibatidum
- Manufacturer
- GlaxoSmithKline (Ireland) Limited
- Country
- Poland (PL)
- ATC code
- B01AC16
- ATC class
- Eptifibatide
- Defined daily dose
- 0.2 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990864317
- gtin05901878600666
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for eptifibatide.
Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eptifibatide · interactions on record
203 records
- 62 severe
- 76 moderate
- 65 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eptifibatide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEptifibatide Accord 2 mg/mlAccord Healthcare
- SpainEPTIFIBATIDA ACCORD 2 MG/ML SOLUCION INYECTABLE EFGAccord Healthcare S.L.U.
- SwedenEptifibatide Accord 2 mg/ml Injektionsvätska, lösningAccord Healthcare S.L.U.
- FinlandEptifibatide MylanMylan Hospital AS
- IcelandEptifibatide AccordAccord Healthcare S.L.U.
- NorwayEptifibatide AccordAccord Healthcare S.L.U.
- CzechiaEPTIFIBATIDE ACCORDAccord Healthcare S.L.U., Barcelona
- United StateseptifibatideSagent Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Bulgaria · Ептифибатид Ромфарм
- Germany · Eptifibatid, Eptifibatid Altamedics
- Denmark · Eptifibatide "ctruz"
- Finland · Eptifibatide Ctruz
- United Kingdom (Northern Ireland) · Eptifibatide Kensington Pharma
- Hungary · Eptifibatide Rompharm
- Ireland · Eptifibatide Jed
- Iceland · Eptifibatide Accord
- Italy · Eptifibatide Alida
- Liechtenstein · Eptifibatide Accord
- Netherlands · Eptifibatide Aftpharm
- Norway · Eptifibatide Accord, Eptifibatide Ctruz
- Romania · Eptifibatidă Rompharm
- Sweden · Eptifibatide Ctruz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e84114d0-2d33-4a30-a674-f7a1929fbfa1 GET /v1/drugs/e84114d0-2d33-4a30-a674-f7a1929fbfa1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "2 mg/ml",
"packaging": "05909990864317 ¦ Rpz ¦ EU/1/99/109/002 ¦ 17222\n1 fiol. 10 ml\n05901878600666 ¦ Rpz ¦ EU/1/99/109/002 ¦ Delfarma Sp. z o.o. ¦ 130294\n1 fiol. 10 ml",
"substance": "Eptifibatidum 2 mg",
"common_name": "Eptifibatidum",
"pl_product_id": "100100490",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about eptifibatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.